https://www.autmhq.org/profile/bocoran-slot-gacor-hari-ini/profile https://www.autmhq.org/profile/jam-slot-gacor-gampang-menang/profile https://www.autmhq.org/profile/slot-deposit-pulsa/profile https://www.autmhq.org/profile/slot-gacor-terbaru-hari-ini/profile https://www.autmhq.org/profile/link-bocoran-slot-gacor-hari-ini/profile Slot Gacor https://www.portabrace.com/profile/slot-gacor-terbaru-gampang-menang/profile
sbobet https://dogrywka.pl/wp-includes/slot/ Jumpabola https://ogino.co.uk/wp-includes/slot-gacor/ Pragmatic



Drug Company Reports Success in Testing COVID-19 Pill

Drug Company Reports Success in Testing COVID-19 Pill by Khanh Thanh

American drug-maker Merck said Friday that its experimental pill reduced hospitalizations and deaths by half among people infected with COVID-19 in a drug trial.

A drug manufacturer in the US named Merck told Friday newspaper that tablets Their trial halved hospitalizations and deaths in people infected with COVID-19 in a drug trial.

The drug-maker said it will soon ask health officials in the United States and around the world to approve the pill for the treatment of coronavirus.

The drug’s maker said it will soon ask health authorities in the United States and around the world to approve the drug for the treatment of coronavirus.

If cleared, the drug, called molnupiravir, would be the first pill approved for the treatment of COVID-19. All other approved treatments must be injected or given through IV by healthcare workers. A pill can be taken at home and is easier to send around the world.

If all goes well, the drug, called molnupiravir, would be the first pill approved to treat COVID-19. All other approved treatments must be injected or delivered intravenous infusion device by medical staff. This pill can be taken at home and easily shipped around the world.

Dr. William Schaffner is an infectious disease expert at Vanderbilt University who was not involved in the research. He said such a pill would provide treatment to “many more people, much more quickly and, we trust, much less expensively.” And Dr. Anthony Fauci has also said a pill that can be taken at home as soon as people feel sick will help control the virus.

Dr. William Schaffner is an infectious disease expert at Vanderbilt University who was not involved in the study. Such a pill would treat “more people, much faster, and we believe much less expensive,” he said. And Dr Anthony Fauci also said pills that can be taken at home as soon as people feel unwell will help keep the virus under control.

Merck and its partner Ridgeback Biotherapeutics studied 775 people with mild to moderate symptoms of COVID-19 in the US, Europe, Latin America and Africa. The patients also had existing health problems that increased their risk for severe disease.

  Practice listening to the VOA 90 medical English newsletter

Merck and partner Ridgeback Biotherapeutics studied 775 people with the symptoms COVID-19 from light to moderate in the United States, Europe, Latin America, and Africa. Patients with co-existing health problems increase their risk for serious illness.

Patients who received the experimental pill within five days of COVID-19 symptoms had about half the rate of hospitalization and death as those who received a placebo. A placebo is a pill that has an inactive substance. Merck said only about seven percent of the patients who received the experimental pill went to the hospital or died after 30 days compared to 14 percent who received a placebo.

Patients who received the experimental pill within five days of having symptoms of COVID-19 had half the rate of hospitalization and death compared to those who took it. placebo. A placebo is a pill with an inactive substance. Only about 7% of patients who received the experimental pill were hospitalized or died after 30 days, Merck said, compared with 14% of patients who received a placebo.

Patients in the Merck study were not vaccinated for COVID-19. Merck said there were some side effects among both groups but did not describe them. The drug-maker said its pill works by preventing the virus from easily replicating itself. But earlier studies showed the drug did not help people who were already very sick.

The patients in the Merck study were not vaccinated against COVID-19. Merck said there were some side effects between both groups but did not describe them. The drug’s maker says its pill works by stopping the virus from easily reproducing on its own. But earlier studies showed the drug did not help people who were already very sick.

A group of independent experts following the trial advised Merck to stop it early because the pill seemed to be working so well. Merck said it will soon send the trial results to the US Food and Drug Administration (FDA) for review.

An independent team of experts after the trial advised Merck to stop the trial soon because the pill appeared to be working very well. Merck said it will soon submit the test results to the U.S. Food and Drug Administration (FDA) for review.

Dr. Dean Li is the vice president of Merck Research Laboratories. He said: “It exceeded what I thought the drug might be able to do in this clinical trial.” Li noted that a 50 percent reduction in hospitalization or death is “a significant clinical impact.”

  Bài dịch: Viêm hạch bạch huyết do vắc xin BCG

Dr. Dean Li is vice president of Merck Research Laboratories. “This pill is beyond what I thought it could do in the trial,” he said clinical this.” Dr. Li notes that a 50% reduction in hospitalization or death is “one impact clinical significantly.”

Merck said it can produce 10 million treatments by the end of the year. The US already plans to buy nearly 2 million treatments if it is approved by the FDA.

Merck says it can produce 10 million tablets by the end of the year. The US already plans to buy nearly 2 million tablets if it is approved by the FDA.

Pfizer and Roche, two other drug companies, are working on similar products and may have results from their drug trials soon.

Pfizer and Roche, two other pharmaceutical companies, are working on similar products and may soon have results from their drug trials.

I’m Dan Friedell.
Dan Friedell adapted this story for Learning English based on a report by The Associated Press. Susan Shand and Hai Do were the editors.
___________________________________________________________________

Words in This Story

pill – n. a small, rounded object you swallow and that contains medicine, vitamins, etc.
(tablets)

IV– n. a device that is used to allow a fluid (such as blood or a liquid medication) to flow directly into a patient’s veins
(intravenous infusion device)

mild – adj. not harsh
(light, gentle, not harsh)

symptoms – n. a change in the body or mind which indicates that a disease is present
(physical symptoms)

placebo – n. a pill or substance that is given to a patient like a drug but that has no physical effect on the patient
(placebo)

exceed – v. to be better than (something)
(beyond, much better)

clinical – adj. relating to or based on work done with real patients : of or relating to the medical treatment that is given to patients in hospitals, clinics, etc.
(clinical)

significant – adj. large in amount, size, or number
(significant, important)

impact – n. a major influence or effect
(influence, impact)

Leave a Reply

https://c.mi.com/thread-4099158-1-0.html https://aariwork.in/wp-includes/article/ https://www.escapefromwatchtower.com/ https://thebakersavenue.com/wp-includes/slot-online/ https://a3anjou.com/community/profile/bocoran-slot-gacor-hari-ini/ https://kitzap.co.uk/community/profile/bocoran-slot-gacor-hari-ini/ https://crazy-stir.com/community/profile/jam-slot-gacor/ https://gmisr.org/forum/profile/bocoran-slot-gacor-hari-ini/ https://isawamovie.com/community/profile/agen-slot-gacor-hari-ini/ https://a3anjou.com/community/profile/judi-slot-terbaru/